Recruiting NA Treatment for Opioid Use Disorder

New treatment option for Treatment for Opioid Use Disorder

Official title A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals

ClinicalTrials.gov ID: NCT07405398

What this study is testing

What it's testing
To train a machine learning model/algorithm for an evaluation of the use of biometric data captured at the wrist for the identification of acute opioid use events and the quantification of opioid withdrawal in opioid dependent individuals.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 22 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Male or female
  • Age ≥22 years at signing of informed consent
  • Patients with a DSM-5 diagnosis of OUD who are eligible for MOUD induction with methadone or buprenorphine

You likely can't join if

  • Sleeve tattoo covering the wrist
  • Subject unable to independently navigate and operate smartwatch applications
  • Subject not proficient with written and spoken English
  • Subject determined likely to be non-compliant by physician/HCP
  • Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures...
  • History or evidence of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator, would pose a risk...
See the full eligibility criteria
Who can join
  • Male or female
  • Age ≥22 years at signing of informed consent
  • Patients with a DSM-5 diagnosis of OUD who are eligible for MOUD induction with methadone or buprenorphine
What rules you out
  • Sleeve tattoo covering the wrist
  • Subject unable to independently navigate and operate smartwatch applications
  • Subject not proficient with written and spoken English
  • Subject determined likely to be non-compliant by physician/HCP
  • Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.
  • History or evidence of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator, would pose a risk to subject safety or interfere with the study evaluation, procedures or...
  • Subject has diminished decision making capability

The study team makes the final eligibility decision.

Where it's taking place

  • Wilmington, North Carolina, United States
  • Austin, Texas, United States
  • Cedar Park, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 22 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Wilmington, North Carolina, United States; Austin, Texas, United States; Cedar Park, Texas, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.